UTAH MEDICAL PRODUCTS INC
For the period ended Dec 31, 2025. Filed Mar 27, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 27, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Market Information
UTMD's common stock trades on the NASDAQ Global Market (stock symbol: UTMD). The following table sets forth the high and low sales price information as reported by NASDAQ for the periods indicated:
| 2025 | 2024 | |||
|---|---|---|---|---|
| High | Low | High | Low | |
| 1st Quarter | $65.56 | $55.81 | $85.76 | $68.00 |
| 2nd Quarter | 57.99 | 51.26 | 71.55 | 65.91 |
| 3rd Quarter | 64.22 | 54.60 | 77.33 | 65.60 |
| 4th Quarter | 64.46 | 53.66 | 68.99 | 60.39 |
Stockholders.
The number of beneficial stockholders of UTMD’s common stock as of March 2, 2026 was at least 2,000.
Dividends.
The following sets forth cash dividends paid during the past two years:
| Record Date | Payable Date | Per Share Amount |
|---|---|---|
| March 15, 2024 | April 3, 2024 | 0.300 |
| June 14, 2024 | July 5, 2024 | 0.300 |
| September 20, 2024 | October 4, 2024 | 0.300 |
| December 16, 2024 | January 3, 2025 | 0.305 |
| March 14, 2025 | April 3, 2025 | 0.305 |
| June 16, 2025 | July 3, 2025 | 0.305 |
| September 17, 2025 | October 2, 2025 | 0.305 |
| December 16, 2025 | January 5, 2026 | 0.310 |
| 2024 total cash dividends paid per share | $ 1.2000 | |
| 2025 total cash dividends paid per share | $ 1.2200 |
Issuer Purchases of Equity Securities.
In 2024, UTMD purchased 301,961 shares of its common stock for $19,968 including commissions and fees (an average price of $66.13/ share). In 2025, UTMD purchased 148,935 shares of its common stock for $8,355 including commissions and fees (an average price of $56.10/ share.)
| 2025 Calendar Quarter | Shares Repurchased | Average Cost Per Share | TotalCost [K] |
|---|---|---|---|
| 1Q 2025 | 54,267 | $ 59.35 | $ 3,221 |
| 2Q 2025 | 64,988 | 53.67 | 3,488 |
| 3Q 2025 | 11,729 | 55.67 | 653 |
| 4Q 2025 | 17,951 | 55.35 | 993 |
| Year Total | 148,935 | $ 56.101 | $ 8,355 |
As a subsequent event, through March 23, 2026 UTMD purchased 1,196 additional shares of its common stock for $67 including commissions and fees (an average price of $55.88/ share).
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.